Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Actifuse MIS
- Development stage
- Unknown
- Lead developer
- Takeda
- Modality
- Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
- Administration
- Implantation
01
Overview
Actifuse MIS is a synthetic bone graft substitute developed by Baxter International Inc., specifically designed for minimally invasive orthopedic procedures. It is a medical device composed of Actifuse ABX, a phase-pure, porous, silicate-substituted calcium phosphate (SiCaP) material containing 0.8% silicon by weight. The product is supplied as 1-2 mm granules suspended in an aqueous gel carrier, allowing for controlled delivery through a cannula. Actifuse MIS acts as an osteoconductive and osteostimulatory scaffold, promoting accelerated bone formation by enhancing local silicon levels. It is indicated for filling bone voids or gaps in the skeletal system, including the extremities, pelvis, and spine, and is intended to be resorbed and replaced by the patient's natural bone during the healing process.
- Brand names
- Actifuse MIS
- Other names
- Actifuse
Beyond the preview
Go deeper on Actifuse MIS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Actifuse MIS.